News for Immunocore Holdings Stock (IMCR)

Immunocore: KIMMTRAK Adoption Continues At Rapid Pace, Expanding To New Markets, Reiterate Buy

Seeking Alpha • 08/27/23

Immunocore Reports Second Quarter 2023 Financial Results and Provides Business Update

GlobeNewsWire • 08/10/23

Why Earnings Season Could Be Great for Immunocore (IMCR)

Zacks Investment Research • 08/08/23

Immunocore to report second quarter 2023 financial results and host call on August 10, 2023

GlobeNewsWire • 08/03/23

August MDA Breakout Stocks Week 31 - 2023: High-Frequency Gainers To Give You An Edge

Seeking Alpha • 07/31/23

Immunocore Holdings: Unlocking The Immune System's Hidden Potential

Seeking Alpha • 06/11/23

Immunocore presents additional ctDNA data from the KIMMTRAK Phase 3 trial at ASCO

GlobeNewsWire • 06/03/23

Immunocore Reports First Quarter 2023 Financial Results and Provides Business Update

GlobeNewsWire • 05/10/23

Immunocore to present at the Bank of America Securities 2023 Health Care Conference

GlobeNewsWire • 05/03/23

Immunocore presents new KIMMTRAK data confirming association between early ctDNA reduction and longer overall survival

GlobeNewsWire • 04/18/23

Immunocore to present at the 22nd Annual Needham Virtual Healthcare Conference

GlobeNewsWire • 04/11/23

Immunocore Holdings PLC Sponsored ADR (IMCR) is Attracting Investor Attention: Here is What You Should Know

Zacks Investment Research • 03/30/23

Immunocore Holdings PLC Sponsored ADR (IMCR) Is a Trending Stock: Facts to Know Before Betting on It

Zacks Investment Research • 03/16/23

Immunocore to present four posters at AACR Annual Meeting 2023

GlobeNewsWire • 03/14/23

Immunocore Holdings plc (IMCR) Q4 2022 Earnings Call Transcript

Seeking Alpha • 03/01/23

Immunocore Reports 2022 Financial Results and Provides Business Update

GlobeNewsWire • 03/01/23

Is a Surprise Coming for Immunocore (IMCR) This Earnings Season?

Zacks Investment Research • 02/28/23

Immunocore Holdings: A Meteoric Rise Likely Here To Stay

Seeking Alpha • 02/27/23

Investors Heavily Search Immunocore Holdings PLC Sponsored ADR (IMCR): Here is What You Need to Know

Zacks Investment Research • 02/24/23

Immunocore to Report Fourth Quarter and Full Year 2022 Earnings and Host Call on March 1, 2023

GlobeNewsWire • 02/23/23

Immunocore announces initial Phase 1 safety and pharmacodynamic activity data with first soluble TCR therapy for people living with HIV

GlobeNewsWire • 02/22/23

Immunocore Holdings PLC Sponsored ADR (IMCR) Surges 6.5%: Is This an Indication of Further Gains?

Zacks Investment Research • 02/14/23

Biotech's Drug Pipeline Expands From Melanoma To Other Cancers

Investors Business Daily • 02/13/23

Is Biotech Immunocore About To Make A 25% Price Move?

MarketBeat • 02/07/23

IPO Stock Of The Week: Biotech Leader Immunocore Approaches Latest Buy Point

Investors Business Daily • 02/03/23